Ajay Surya (@ajaysurya37) header
Ajay Surya (@ajaysurya37) profile picture

Chartered Accountant. Equities during day @niveshaay & sometimes Writer at night. In between, a true Dhoni lover & a human trying to humane..

Surat, India
Joined September 2013
Photo by Ajay Surya (@ajaysurya37)Photo by Ajay Surya (@ajaysurya37)Photo by Ajay Surya (@ajaysurya37)Photo by Ajay Surya (@ajaysurya37)Photo by Ajay Surya (@ajaysurya37)Photo by Ajay Surya (@ajaysurya37)Photo by Ajay Surya (@ajaysurya37)Photo by Ajay Surya (@ajaysurya37)Photo by Ajay Surya (@ajaysurya37)Photo by Ajay Surya (@ajaysurya37)
to my impending Tara, every single time that breeze of loneliness tingle me, I go back to humming “agar tum saath ho” and I so want to cry “pal bhar thahar jao” to you but just can’t. #6yearsoftamasha #ImtiazAli #Tamasha
4
13
3
47
Ajay Surya retweeted
What happens when Surti ambition meets Surti capital? 👀 Three different businesses. One city. At The Dhandho Valley ’26, Surat's entrepreneurs shared how they're building businesses beyond the city's traditional strengths. Could Surat be India's next big investment story? 🎥 Watch the full conversation on YouTube: youtu.be/HAC7UI1DR4E Featuring: Vishal S. Budia (Chairman & MD, Steamhouse India), Harmeet Gandhi & Shyam Rungta (Directors, Regain Energies) and Shetal Mehta (Founder, Suchi Semicon). @arvind_kothari @KabraGunjan @csvikramsharma #TheDhandhoValley #TDV2026 #Niveshaay #Surat #Entrepreneurship
1
2
9
2,559
Ethos Limited - volume growth in terms of number of watches looks solid.
I am not a watch person. But this chart surprised me. Indians buy 2.4x the Swiss watches they did 10 years ago, even as the world bought fewer in 2024 and 2025. In 2015 India was the 26th biggest market for Swiss watches. Today it is 14th. Which made me curious: what are the homegrown Indian watches that people do not know much about? Would love to know. (Not the usual Titan, Fastrack, Sonata etc.) Data: Federation of the Swiss Watch Industry.
8
516
What a journey -> Been tracking #HLEGlascoat through every phase. Good times. Tough times. Acquisitions. Turnarounds. Through every phase, one thing never changed: Management’s Resilience. Orderbook now crosses 1000+ cr #investing
Heard a lot about multibagger stories. Glad to witness one so closely. Made a small thread on the learnings, process and the need to avoid biases, Do read. “The only bias we should have as investors is to be biased towards nothing.” #HLEGlascoat #HLE #GMM #investing #chemical
7
717
AN INNINGS NO ONE WILL EVER FORGET. - Thank you, Maxi. 🫡
108
1,478
68
24,944
267,562
Ajay Surya retweeted
📍Session Highlights TDV3.0 | Surti Companies Backed by Surti Capital Who says big innovations need big cities?🚀 At The Dhandho Valley ’26, leaders from Steamhouse India, Regain Energies Solutions and Suchi Semicon showcased how Surat is making its mark across industrial utilities, solar recycling and semiconductors. From local capital to businesses built with strong competitive moats, the conversation revealed why Surat's next growth story is worth watching. 👉Swipe through for the key takeaways! @arvind_kothari @KabraGunjan @csvikramsharma #TheDhandhoValley #TDV2026 #Niveshaay #Surat #SteamhouseIndia #RegainEnergies #SuchiSemicon #Innovation #MakeInIndia
2
4
27
2,571
12th co from Niveshaay’s stable to get listed. Great timing as given the state of the markets a lot of people are going to need Stents 🤣
From Surat to 70+ countries! 🇮🇳 Sahajanand Medical Technologies (SMT) has built one of India’s leading drug-eluting stent franchises, competing with global medtech giants, with nearly 25% domestic market share by volume. Beyond India, SMT has established a strong global presence, with nearly 2/3rd of its revenue coming from international markets, led by Europe. Congratulations to the entire SMT team on their stock market listing! Another proud milestone for Surat, and many more to come! 🚀 @arvind_kothari @KabraGunjan @csvikramsharma #Niveshaay #SMT #SahajanandMedicalTechnologies #IPO #MadeInIndia #MedTech #Surat #BhargavKotadia
2
3
85
8,725
Ajay Surya retweeted
From Surat to 70+ countries! 🇮🇳 Sahajanand Medical Technologies (SMT) has built one of India’s leading drug-eluting stent franchises, competing with global medtech giants, with nearly 25% domestic market share by volume. Beyond India, SMT has established a strong global presence, with nearly 2/3rd of its revenue coming from international markets, led by Europe. Congratulations to the entire SMT team on their stock market listing! Another proud milestone for Surat, and many more to come! 🚀 @arvind_kothari @KabraGunjan @csvikramsharma #Niveshaay #SMT #SahajanandMedicalTechnologies #IPO #MadeInIndia #MedTech #Surat #BhargavKotadia
2
4
1
45
11,297
Ajay Surya retweeted
📍Session Highlights TDV3.0 | Switching Lanes to Electric India’s EV revolution is picking up speed, and the opportunities go far beyond vehicles! ⚡ At The Dhandho Valley ’26, industry leaders from Omega Seiki Mobility, RACL Geartech and Shivalik Bimetal Controls explored what’s accelerating India’s electric mobility future. From policy-driven demand and precision manufacturing to component localisation and energy independence, the discussion highlighted the forces powering the next wave of EV growth. Swipe through to discover what’s driving India’s electric future! 🚀 @arvind_kothari @KabraGunjan @csvikramsharma @ajaysurya37 #RajAgrawal #TheDhandhoValley #TDV2026 #Niveshaay #OmegaSeikiMobility #RACLGeartech #ShivalikBimetalControls #SwitchingLanesToElectric #ElectricVehicles #EVIndia #ElectricMobility #MakeInIndia
3
23
2,517
Great to be at Dhandho Valley 2026, organised by Niveshaay in Surat last week. Joined Sumer Ghumman of Shivalik Bimetal Controls and Uday Narang of Omega Seiki Mobility for a panel discussion on “Switching Lanes to Electric”, exploring the EV transition and India’s opportunity in global manufacturing. Equally encouraging was the curiosity around RACL Geartech in conversations on the sidelines, with investors keen to understand our growth journey, manufacturing capabilities and global ambitions. A proud moment for Team RACL. The interest we are seeing is a reflection of the hard work, commitment and continuous progress of our people in building a globally competitive manufacturing organisation. Thank you to Arvind Kothari and the entire Niveshaay team for organising a fantastic event.🇮🇳
2
6
1
74
9,613
Ajay Surya retweeted
From discovering potential to witnessing a ₹5,000 crore milestone. Our journey with Sambhv Steel Tubes began in 2023, not through a broker report or a conference, but through Saket Agarwal, our LP and one of Sambhv’s largest distributors. He introduced us to a Raipur-based company, led by the Goyal family, whose manufacturing capabilities, product quality and cost advantages stood out. Visits to the Raipur facility, management interactions and distributor insights strengthened our conviction in a business built on end-to-end integration, cost efficiencies and, above all, the promoters’ ability to execute and scale. We backed Sambhv with an investment of ₹150 crore at a valuation of ₹750 crore. When the company made its stock market debut in July 2025, our conviction had only grown stronger. We continued our journey as anchor investors in its IPO at a valuation of around ₹2,000 crore. Today, as Sambhv crosses ₹5,000 crore in market capitalisation, it is a proud moment to reflect on this journey. It reinforces something we have always believed at Niveshaay: some of the best investment ideas come from listening to those closest to the business, doing the groundwork and recognising potential early. Heartiest congratulations to the Goyal family and the entire Sambhv Steel Tubes team on this remarkable milestone! सब संभव है! @arvind_kothari @KabraGunjan @csvikramsharma #SambhvSteelTubes #Niveshaay #SabSambhavHai #InvestmentJourney #ConvictionInvesting #GroundLevelResearch #LongTermInvesting #ValueInvesting #IndianManufacturing #SteelIndustry #MilestoneMoment
2
5
43
3,053
Ajay Surya retweeted
Different panels. Different perspectives. One room looking at what’s next. From Compute & Capital to भारत & Orbit, conversations that questioned, challenged and opened up new perspectives. A few frames from the conversations that shaped The Dhandho Valley 3.0. @arvind_kothari @KabraGunjan @csvikramsharma #TheDhandhoValley #TDV3 #TDV2026 #Niveshaay #Compute #AI #Space #Orbit #BESS #Entrepreneurship #Surat
7
44
3,956
For two incredible days, we lived and breathed big ideas, sharp strategies, networking, and the pure spirit of entrepreneurship. “The Dhandho Valley’” wraps up, but the quest to ‘Dhandho’ keeps rolling on! Let’s get to work! 🚀 @niveshaay #thedhandhovalley #TDV3 #niveshaay
2
2
53
2,845
You are what you think. You become what you do. Thoughts decide who you want to be. Habits decide who you are.
6
413
Ajay Surya retweeted
An unexpected day for all the Listings Today But now everything is into a good zone ▪︎ Hy-tech Engineers Listed at 42% Premium now locked in UC ▪︎ Symbiotec Listed at Par now 8-9% above Issue Price ▪︎ Skyways Listed at a deep discount now almost at Issue price Hiccups are part and parcel, good companies will do well, rest will be punished
“A Global Leader in Corticosteroids APIs from Indore, Making in India For The World” Symbiotec Pharmalab Limited IPO Detailed Analysis Applying For Reasonable Listing Gains And Long-term Highlights of the Issue : Date : 24-27 August Price Band : 938-988 Size : 1,757 Crore Fresh - 150 Crore PAT - 1,607 Crore M.cap : 6,349 Crore Objects Of The Issue : ▪︎ Repayment Of Debt - 112.5 Cr ▪︎ GCP - 37.5 Cr Key Pointers : ▪︎ Symbiotec is a Global Leader in Corticosteroid Active Pharmaceutical Ingredients (API) with a market share of 38.2% and steroidal hormone APIs with a market share of 23.8% ▪︎ It's A R&D driven pharma and Biotech company with strength in Organic chemistry, biotechnology and Complex Injectables ▪︎ The Company has fully backward integrated operations supported by vertical integration, it is approved by US FDA, EU GMP and other major regulators ▪︎ Their portfolio includes over 60 APIs such as Hydrocortisones, Betamethasones, Progesterone, Methylprednisolones, Estrogens, Testosterones, and global Monopoly in Hydrocortisone (80% share), Testosterone (76.4%) and Methylprednisolones (76%) ▪︎ The company holds 43 US FDA drug master files and 23 EDQM certificates, with differentiated chemistry enabling up to 400 synthesis steps under cGMP. They are among the few globally developing conjugated estrogens. Their backward integration covers over 80% of products by revenue, using microbial strains to produce steroid and hormone precursors ▪︎ Fermentation capabilities span biotransformation of soy sterols, classical fermentation for anti-infectives and enzymes, recombinant protein expression for GLP-1 and Insulin, and precision fermentation for nutraceuticals and alternate proteins ▪︎ The company supplies products through three verticals—API products, CDMO services, and complex injectables, serving over 200 clients in 40+ countries. Their forward integration centres on double chamber vials, bags, and syringes, scaled for commercial execution using in-house materials ▪︎ Over three fiscals, Symbiotec invested has 799 crore to expand API and injectables capacity and signed contracts to supply complex biotechnology products worldwide ▪︎ The Company is working on new product verticals and upgrading itself into a consumption driven Formulations Company making it a Rare Multi-spectral platform Financials and Personal Assumptions : (In Crores) FY24 Revenue : 716 EBITDA : 177 PAT : 100 FY25 Revenue : 751.6 EBITDA : 206 PAT : 96.8 FY26 Revenue : 879 EBITDA : 232 PAT : 110 FY27E Revenue : 1,100 EBITDA : 270 PAT : 130 FY28E Revenue : 1,380 EBITDA : 375 PAT : 190 Valuing Symbiotec at 25× FY28E EV/EBITDA, Anticipated Value Comes At 1423, Implying An Upside Of 44% As the new verticals scale, the approval for vials kick-in and capacities start ramping up the Multiples will be upgraded to 30× A Fantastic, One of a kind, Rare Platform, obviously Numbers will take some time to shape up Sad to see people being so pessimistic for all the wrong reasons, inappropriate comments being passed without understanding the subject well Great Capabilities, No other Indian Company has such capabilities, on the fermentation side can be slightly compared with Laurus and very small comparison with Concord and Biocon, obviously segments are very different Very Reasonable Valuations, Great Anchor Book, Great Pre-IPO Names, Extremely High Quality Management and Promoters The Overhang of Further Supply from MOPE and InvAscent and growth not coming on expected lines acting as major negatives Just A Personal View, Only For Educational Purposes
11
13
272
58,162
19:29. A time we’ll never forget! 🥹 #WhistlePodu
41
848
34
8,502
272,095
Ajay Surya retweeted
Make in India has always been a powerful idea. But for us, the opportunity lies in looking deeper than the headline. Over the years, India has built capabilities across manufacturing value chains. Today, policy-led demand, import substitution, shifting global supply chains and a growing focus on self-reliance are creating opportunities in specific parts of this ecosystem. Our lens is becoming sharper. Where structural demand meets emerging domestic capability, where capacity is still catching up, barriers to entry matter, and Indian businesses have the opportunity to scale. It is not simply about participating in India’s manufacturing story. It is about identifying where the value is being created within it. This Independence Day, we bring Make in India theme back into focus, with a more focused lens on the opportunities shaping India’s manufacturing journey. niveshaay.smallcase.com/ @arvind_kothari @KabraGunjan @csvikramsharma #Niveshaay #MakeInIndia #IndianManufacturing #IndiaGrowthStory #AtmanirbharBharat #ImportSubstitution #ManufacturingEcosystem #IndianEquities #ViksitBharat
5
11
2,422
“DHANDA. BANDA. WAQT” With the one and only @Amit_Jeswani1 🤩 @ias_summit
2
3
127
11,378
Ajay Surya retweeted
We have been invested in ICE Make for many years and have had the privilege of witnessing its remarkable journey, from a ₹100 crore revenue company to one now at over ₹700 crore. Being based in Gujarat, we've seen firsthand the strength of the brand, its growing market presence, and the trust it has built over the years. We've always enjoyed engaging with the management, understanding their capital allocation decisions, discussing their long-term growth plans, and attending their AGMs. A big congratulations to the entire ICE Make team on the joint venture with Galilei, Japan and the ₹190 crore preferential equity investment. This partnership is an important milestone that should further strengthen the company's brand positioning, broaden its product portfolio, and expand its market presence. Wishing the team continued success as they embark on this exciting new chapter. @arvind_kothari @KabraGunjan @csvikramsharma
1
5
27
2,972
lol #Jaipur now. Why? Some VIP movement in Delhi didn’t give landing permission 🙂 #delhi #bangalore #mumbai
Delhi today, Bangalore tomorrow, Mumbai next. Let’s catch up
1
5
955